iomeprol has been researched along with Urogenital Neoplasms in 2 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Urogenital Neoplasms: Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harieaswar, S | 1 |
| Rajesh, A | 1 |
| Griffin, Y | 1 |
| Tyagi, R | 1 |
| Morgan, B | 1 |
| Diederich, S | 1 |
2 other studies available for iomeprol and Urogenital Neoplasms
| Article | Year |
|---|---|
Routine use of positive oral contrast material is not required for oncology patients undergoing follow-up multidetector CT.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Barium Sulfate; Contrast Media; Digestive Syst | 2009 |
[Are oral contrast media required for follow-up assessments?].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Barium Sulfate; Contrast Media; Digestive Syst | 2009 |